<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03141450</url>
  </required_header>
  <id_info>
    <org_study_id>449/2559</org_study_id>
    <nct_id>NCT03141450</nct_id>
  </id_info>
  <brief_title>Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With CPB</brief_title>
  <official_title>Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical site infection (SSI) is a serious operative complication that may be associated with
      any surgical procedures. It increases morbidity and mortality after cardiac surgery. Plasma
      concentration of prophylactic antibiotic, routinely cefazolin, is altered by effects of
      cardiopulmonary bypass. This study is conducted to measure the plasma concentrations of
      cefazolin to determine its adequacy in pediatric patients undergoing elective cardiac surgery
      with cardiopulmonary bypass including its correlation with the incidence of postoperative
      SSI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>plasma concentration of cefazolin in pediatric cardiopulmonary bypass</measure>
    <time_frame>12 hours</time_frame>
    <description>plasma concentration of cefazolin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of surgical site infection after elective pediatric cardiac surgery</measure>
    <time_frame>30 days</time_frame>
    <description>surgical site infection</description>
  </secondary_outcome>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Surgical Site Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients whose age less than 7 years old, undergo elective cardiac surgery with
        cardiopulmonary bypass.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age &lt; 7 years old

          2. undergoing elective cardiac surgery with cardiopulmonary bypass

          3. receive cefazolin as prophylactic antibiotic

        Exclusion Criteria:

          1. Known or family history of penicillin or cephalosporins allergy

          2. Coexisting liver or renal disease

          3. Previous infection or received any antibiotics within 4 weeks

          4. Previous surgery with median sternotomy

          5. Predicted cardiopulmonary bypass time of less than 30 minutes or more than 150 minutes

          6. Severe hemodynamic instability during the operation, requiring mechanical circulatory
             support
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saowaphak Lapmahapaisan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saowaphak Lapmahapaisan, MD</last_name>
    <phone>6624113256</phone>
    <email>Saowaphak.lap@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Viriya Maisart, MD</last_name>
    <phone>662-419-7995</phone>
    <email>pians17@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine, Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saowaphak Lapmahapaisan, MD</last_name>
      <phone>662-419-7995</phone>
      <email>Saowaphak.lap@mahidol.ac.th</email>
    </contact>
    <contact_backup>
      <last_name>Viriya Maisart, MD</last_name>
      <phone>662-419-7995</phone>
      <email>pians17@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Saowaphak Lapmahapaisan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Saowaphak Lapmahapaisan</investigator_full_name>
    <investigator_title>Asst. Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cefazolin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

